SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------
SCHEDULE 13G
(Rule 13d-102)
----------------
INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d-1(b), (c)
AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
ELITE PHARMACEUTICALS, INC.
(Name of Issuer)
COMMON STOCK, $0.01 PAR VALUE PER SHARE
(Title of Class of Securities)
28659T200
(CUSIP Number)
May 2, 2007
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
-----------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 (the "Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however, see
the Notes)
Schedule 13G
CUSIP No. 28659T200 PAGE 2 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner Partners
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
253 Series C 8% Preferred Stock convertible into
109,051.72 Common Shares and 32,715 Warrants
exercisable into 32,715 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
253 Series C 8% Preferred Stock convertible into
109,051.72 Common Shares and 32,715 Warrants
exercisable into 32,715 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
253 Series C 8% Preferred Stock convertible into 109,051.72
Common Shares and 32,715 Warrants exercisable into 32,715
Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.6%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 3 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner Institutional Partners, L.P.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
460 Series C 8% Preferred Stock convertible into
198,275.86 Common Shares and 59,482 Warrants
exercisable into 59,482 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
460 Series C 8% Preferred Stock convertible into
198,275.86 Common Shares and 59,482 Warrants
exercisable into 59,482 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
460 Series C 8% Preferred Stock convertible into 198,275.86
Common Shares and 59,482 Warrants exercisable into 59,482
Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
1.0%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 4 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M. H. Davidson & Co.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
33 Series C 8% Preferred Stock convertible into
14,224.14 Common Shares and 4,267 Warrants
exercisable into 4,267 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
33 Series C 8% Preferred Stock convertible into
14,224.14 Common Shares and 4,267 Warrants
exercisable into 4,267 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
33 Series C 8% Preferred Stock convertible into 14,224.14
Common Shares and 4,267 Warrants exercisable into 4,267
Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.1%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 5 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner International, Ltd.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
807 Series C 8% Preferred Stock convertible into
347,844.83 Common Shares and 104,353 Warrants
exercisable into 104,353 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
807 Series C 8% Preferred Stock convertible into
347,844.83 Common Shares and 104,353 Warrants
exercisable into 104,353 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
807 Series C 8% Preferred Stock convertible into 347,844.83
Common Shares and 104,353 Warrants exercisable into 104,353
Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
1.8%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 6 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Serena Limited
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
20 Series C 8% Preferred Stock convertible into
8,620.69 Common Shares and 2,586 Warrants exercisable
into 2,586 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
20 Series C 8% Preferred Stock convertible into
8,620.69 Common Shares and 2,586 Warrants exercisable
into 2,586 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
20 Series C 8% Preferred Stock convertible into 8,620.69
Common Shares and 2,586 Warrants exercisable into 2,586
Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.0%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 7 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner Healthcare Fund LP
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
2,060 Series C 8% Preferred Stock convertible into
887,931.03 Common Shares and 266,379 Warrants
exercisable into 266,379 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
2,060 Series C 8% Preferred Stock convertible into
887,931.03 Common Shares and 266,379 Warrants
exercisable into 266,379 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
2,060 Series C 8% Preferred Stock convertible into 887,931.03
Common Shares and 266,379 Warrants exercisable into 266,379
Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
4.7%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 8 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner Healthcare International Ltd.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants exercisable
into 392,327 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
6.9%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
CO
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 9 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MHD Management Co.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
253 Series C 8% Preferred Stock convertible into
109,051.72 Common Shares and 32,715 Warrants
exercisable into 32,715 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
253 Series C 8% Preferred Stock convertible into
109,051.72 Common Shares and 32,715 Warrants
exercisable into 32,715 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
253 Series C 8% Preferred Stock convertible into 109,051.72
Common Shares and 32,715 Warrants exercisable into 32,715
Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
0.6%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 10 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner Advisers Inc.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
460 Series C 8% Preferred Stock convertible into
198,275.86 Common Shares and 59,482 Warrants
exercisable into 59,482 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
460 Series C 8% Preferred Stock convertible into
198,275.86 Common Shares and 59,482 Warrants
exercisable into 59,482 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
460 Series C 8% Preferred Stock convertible into 198,275.86
Common Shares and 59,482 Warrants exercisable into 59,482
Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
1.0%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IA
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 11 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Davidson Kempner International Advisors, L.L.C.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
827 Series C 8% Preferred Stock convertible into
356,465.52 Common Shares and 106,939 Warrants
exercisable into 106,939 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
827 Series C 8% Preferred Stock convertible into
356,465.52 Common Shares and 106,939 Warrants
exercisable into 106,939 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
827 Series C 8% Preferred Stock convertible into 356,465.52
Common Shares and 106,939 Warrants exercisable into 106,939
Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
1.9%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
OO
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 12 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DK Group LLC
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
2,060 Series C 8% Preferred Stock convertible into
887,931.03 Common Shares and 266,379 Warrants
exercisable into 266,379 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
2,060 Series C 8% Preferred Stock convertible into
887,931.03 Common Shares and 266,379 Warrants
exercisable into 266,379 Common Shares
------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
2,060 Series C 8% Preferred Stock convertible into 887,931.03
Common Shares and 266,379 Warrants exercisable into 266,379
Common Shares
------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
4.7%
------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
OO
------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 13 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DK Management Partners LP
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants exercisable
into 392,327 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
6.9%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 14 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DK Stillwater GP LLC
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants exercisable
into 392,327 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
6.9%
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
OO
--------------------------------------------------------------------------------
Schedule 13G
CUSIP No. 28659T200 PAGE 15 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Thomas L. Kempner, Jr.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants exercisable
into 862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(1)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
_____________________
(1) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 16 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Marvin H. Davidson
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants exercisable
into 862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(2)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
__________________
(2) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 17 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Stephen M. Dowicz
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants exercisable
into 862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(3)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
__________________
(3) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 18 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Scott E. Davidson
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants exercisable
into 862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(4)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
___________________
(4) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 19 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Michael J. Leffell
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants exercisable
into 862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(5)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
______________
(5) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 20 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Timothy I. Levart
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom & United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
---------------------------=----------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common and 862,109 Warrants exercisable into
862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(6)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
________________
(6) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 21 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert J. Brivio, Jr.
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common and 862,109 Warrants exercisable into
862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(7)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
___________________
(7) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 22 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Eric P. Epstein
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants exercisable
into 862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(8)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
_____________________
(8) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 23 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Anthony A. Yoseloff
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants exercisable
into 862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(9)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
_____________________
(9) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 24 OF 46
--------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Avram Z. Friedman
--------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
(3) SEC USE ONLY
--------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF (5) SOLE VOTING POWER
0
SHARES --------------------------------------------------------------
BENEFICIALLY (6) SHARED VOTING POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
OWNED BY --------------------------------------------------------------
EACH (7) SOLE DISPOSITIVE POWER
0
REPORTING --------------------------------------------------------------
PERSON WITH (8) SHARED DISPOSITIVE POWER
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
--------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED
BY EACH REPORTING PERSON
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants exercisable
into 862,109 Common Shares
--------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
--------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)
9.9%(10)
--------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
______________________
(10) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 25 OF 46
--------------------------------------------------------------------------------
ITEM 1(a). NAME OF ISSUER:
Elite Pharmaceuticals, Inc. (the "Company")
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
165 Ludlow Avenue
Northvale, NJ 07647
ITEM 2(a). NAME OF PERSON FILING:
This Statement is filed by each of the entities and persons listed
below, all of whom together are referred to herein as the "Reporting Persons":
(i) Davidson Kempner Partners, a New York limited
partnership ("DKP");
(ii) Davidson Kempner Institutional Partners, L.P., a
Delaware limited partnership ("DKIP");
(iii) M. H. Davidson & Co., a New York limited partnership
("CO");
(iv) Davidson Kempner International, Ltd., a British Virgin
Islands corporation ("DKIL");
(v) Serena Limited, a Cayman Islands corporation ("Serena");
(vi) Davidson Kempner Healthcare Fund LP, a Delaware limited
partnership ("DKHF");
(vii) Davidson Kempner Healthcare International Ltd., a Cayman
Islands corporation ("DKHI");
(viii) MHD Management Co., a New York limited partnership and
the general partner of DKP ("MHD");
(ix) Davidson Kempner Advisers Inc., a New York corporation
and the general partner of DKIP ("DKAI"), which is
registered as an investment adviser with the U.S.
Securities and Exchange Commission;
(x) Davidson Kempner International Advisors, L.L.C., a
Delaware limited liability company and the manager of
DKIL and Serena ("DKIA");
(xi) DK Group LLC, a Delaware limited liability company and
the general partner of DKHF ("DKG");
(xii) DK Management Partners LP, a Delaware limited
partnership and the investment manager of DKHI ("DKMP");
Schedule 13G
CUSIP No. 28659T200 PAGE 26 OF 46
(xiii) DK Stillwater GP LLC, a Delaware limited liability
company and the general partner of DKMP ("DKS"); and
(xiv) Messrs. Thomas L. Kempner, Jr., Marvin H. Davidson,
Stephen M. Dowicz, Scott E. Davidson, Michael J.
Leffell, Timothy I. Levart, Robert J. Brivio, Jr.,
Anthony A. Yoseloff, Eric P. Epstein and Avram Z.
Friedman (collectively, the "Principals"), who are the
general partners of CO and MHD, the sole managing
members of DKIA and DKG and the sole stockholders of
DKAI. Messrs. Thomas L. Kempner, Jr. and Timothy I.
Levart are Executive Managing Member and Deputy
Executive Managing Member, respectively, of DKS. Each of
Messrs. Kempner and Levart, together with Messrs. Marvin
H. Davidson, Stephen M. Dowicz, Scott E. Davidson,
Michael J. Leffell, Robert J. Brivio, Jr., Anthony A.
Yoseloff, Eric P. Epstein and Avram Z. Friedman are
limited partners of DKMP.
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE:
The address of the principal business office of each of the Reporting
Persons is c/o Davidson Kempner Partners, 65 East 55th Street, 19th Floor, New
York, New York 10022.
ITEM 2(c). CITIZENSHIP:
(i) DKP - a New York limited partnership
(ii) DKIP - a Delaware limited partnership
(iii) CO - a New York limited partnership
(iv) DKIL - a British Virgin Islands corporation
(v) Serena - a Cayman Islands corporation
(vi) DKHF - a Delaware limited partnership
(vii) DKHI - a Cayman Islands corporation
(viii) MHD - a New York limited partnership
(ix) DKAI - a New York corporation
(x) DKIA - a Delaware limited liability company
(xi) DKG - a Delaware limited liability company
(xii) DKMP - a Delaware limited partnership
(xiii) DKS - a Delaware limited liability company
(xiv) Thomas L. Kempner, Jr. - United States
(xv) Marvin H. Davidson - United States
(xvi) Stephen M. Dowicz - United States
(xvii) Scott E. Davidson -United States
(xviii) Michael J. Leffell - United States
Schedule 13G
CUSIP No. 28659T200 PAGE 27 OF 46
(xix) Timothy I. Levart - United Kingdom & United States
(xx) Robert J. Brivio, Jr. - United States
(xxi) Eric P. Epstein - United States
(xxii) Anthony A. Yoseloff - United States
(xxiii) Avram Z. Friedman - United States
ITEM 2(d). TITLE OF CLASS OF SECURITIES:
COMMON STOCK, $0.01 PAR VALUE PER SHARE
ITEM 2(e). CUSIP NUMBER:
28659T200
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO 13d-1(b) OR 13d-2(b) OR
(c), CHECK WHETHER THE PERSON FILING IS A:
(a) [ ] Broker or dealer registered under Section 15 of the Act;
(b) [ ] Bank as defined in Section 3(a)(6) of the Act;
(c) [ ] Insurance Company as defined in Section 3(a)(19)
of the Act;
(d) [ ] Investment Company registered under Section 8 of the
Investment Company Act of 1940;
(e) [ ] Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940:
see Rule 13d-1(b)(1)(ii)(E);
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to
the provisions of the Employee Retirement Income Security
Act of 1974 or Endowment Fund;
see Rule 13d-1(b)(1)(ii)(F);
(g) [ ] Parent Holding Company, in accordance with
Rule 13d-1(b)(ii)(G);
(h) [ ] Savings Associations as defined in Section 3(b) of the
Federal Deposit Insurance Act;
(i) [ ] Church Plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the
Investment Company Act of 1940;
(j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Schedule 13G
CUSIP No. 28659T200 PAGE 28 OF 46
ITEM 4. OWNERSHIP.
Subject to the Ownership Limitation (as defined below), the Principals may
be deemed to beneficially own an aggregate of 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants exercisable
into 862,109 Common Shares as a result of their voting and dispositive power
over the 6,667 Series C 8% Preferred Stock convertible into 2,873,706.89 Common
Shares and 862,109 Warrants exercisable into 862,109 Common Shares beneficially
owned by DKP, DKIP, DKIL, Serena, CO, DKHF and DKHI.
DKIA may be deemed to beneficially own the 807 Series C 8% Preferred Stock
convertible into 347,844.83 Common Shares and 104,353 Warrants exercisable into
104,353 Common Shares beneficially owned by DKIL and the 20 Series C 8%
Preferred Stock convertible into 8,620.69 Common Shares and 2,586 Warrants
exercisable into 2,586 Common Shares beneficially owned by Serena as a result of
its voting and dispositive power over those shares. DKAI may be deemed to
beneficially own the 460 Series C 8% Preferred Stock convertible into 198,275.86
Common Shares and 59,482 Warrants exercisable into 59,482 Common Shares owned by
DKIP as a result of its voting and dispositive power over those shares. MHD may
be deemed to beneficially own the 253 Series C 8% Preferred Stock convertible
into 109,051.72 Common Shares and 32,715 Warrants exercisable into 32,715 Common
Shares beneficially owned by DKP as a result of its voting and dispositive power
over those shares. DKG may be deemed to beneficially own the 2,060 Series C 8%
Preferred Stock convertible into 887,931.03 Common Shares and 266,379 Warrants
exercisable into 266,379 Common Shares beneficially owned by DKHF as a result of
its voting and dispositive power over those shares. DKMP and DKS may be deemed
to beneficially own the 3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants exercisable into 392,327 Common
Shares beneficially owned by DKHI as a result of their voting and dispositive
power over those shares.
As set forth in the Certificate of Designation of Preferences, Rights and
Limitations of Series C 8% Convertible Preferred Stock and the Common Stock
Purchase Warrant, respectively, the number of Common Shares into which the
Preferred Stock are convertible and the Warrants are exerciseable is limited to
that number of Common Shares which would result in Davidson Kempner affiliated
entities having aggregate beneficial ownership of not more than 9.99% of the
total issued and outstanding shares of Common Shares (the "Ownership
Limitation").
A. DKP
(a) Amount beneficially owned: 253 Series C 8% Preferred Stock
convertible into 109,051.72 Common Shares and 32,715 Warrants
exercisable into 32,715 Common Shares
(b) Percent of class: 0.6%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 253 Series C
8% Preferred Stock convertible into 109,051.72 Common
Shares and 32,715 Warrants exercisable into 32,715
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
Schedule 13G
CUSIP No. 28659T200 PAGE 29 OF 46
(iv) shared power to dispose or to direct the disposition:
253 Series C 8% Preferred Stock convertible into
109,051.72 Common Shares and 32,715 Warrants exercisable
into 32,715 Common Shares
B. DKIP
(a) Amount beneficially owned: 460 Series C 8% Preferred Stock
convertible into 198,275.86 Common Shares and 59,482 Warrants
exercisable into 59,482 Common Shares
(b) Percent of class: 1.0%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 460 Series C
8% Preferred Stock convertible into 198,275.86 Common
Shares and 59,482 Warrants exercisable into 59,482
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
460 Series C 8% Preferred Stock convertible into
198,275.86 Common Shares and 59,482 Warrants exercisable
into 59,482 Common Shares
C. CO
(a) Amount beneficially owned: 33 Series C 8% Preferred Stock
convertible into 14,224.14 Common Shares and 4,267 Warrants
exercisable into 4,267 Common Shares
(b) Percent of class: 0.1%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 33 Series C
8% Preferred Stock convertible into 14,224.14 Common
Shares and 4,267 Warrants exercisable into 4,267
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition: 33
Series C 8% Preferred Stock convertible into 14,224.14
Common Shares and 4,267 Warrants exercisable into
4,267 Common Shares
D. DKIL
(a) Amount beneficially owned: 807 Series C 8% Preferred Stock
convertible into 347,844.83 Common Shares and 104,353 Warrants
exercisable into 104,353 Common Shares
Schedule 13G
CUSIP No. 28659T200 PAGE 30 OF 46
(b) Percent of class: 1.8%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 807 Series C
8% Preferred Stock convertible into 347,844.83 Common
Shares and 104,353 Warrants exercisable into 104,353
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
807 Series C 8% Preferred Stock convertible into
347,844.83 Common Shares and 104,353 Warrants
exercisable into 104,353 Common Shares
E. Serena
(a) Amount beneficially owned: 20 Series C 8% Preferred Stock
convertible into 8,620.69 Common Shares and 2,586 Warrants
exercisable into 2,586 Common Shares
(b) Percent of class: 0.0%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 20 Series C
8% Preferred Stock convertible into 8,620.69 Common
Shares and 2,586 Warrants exercisable into 2,586
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition: 20
Series C 8% Preferred Stock convertible into 8,620.69
Common Shares and 2,586 Warrants exercisable into 2,586
Common Shares
F. DKHF
(a) Amount beneficially owned: 2,060 Series C 8% Preferred Stock
convertible into 887,931.03 Common Shares and 266,379 Warrants
exercisable into 266,379 Common Shares
(b) Percent of class: 4.7%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 2,060 Series
C 8% Preferred Stock convertible into 887,931.03 Common
Shares and 266,379 Warrants exercisable into 266,379
Common Shares
Schedule 13G
CUSIP No. 28659T200 PAGE 31 OF 46
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
2,060 Series C 8% Preferred Stock convertible into
887,931.03 Common Shares and 266,379 Warrants
exercisable into 266,379 Common Shares
G. DKHI
(a) Amount beneficially owned: 3,034 Series C 8% Preferred Stock
convertible into 1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
(b) Percent of class: 6.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 3,034 Series
C 8% Preferred Stock convertible into 1,307,758.62
Common Shares and 392,327 Warrants exercisable into
392,327 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
H. MHD
(a) Amount beneficially owned: 253 Series C 8% Preferred Stock
convertible into 109,051.72 Common Shares and 32,715 Warrants
exercisable into 32,715 Common Shares
(b) Percent of class: 0.6%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 253 Series C
8% Preferred Stock convertible into 109,051.72 Common
Shares and 32,715 Warrants exercisable into 32,715
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
253 Series C 8% Preferred Stock convertible into
109,051.72 Common Shares and 32,715 Warrants exercisable
into 32,715 Common Shares
Schedule 13G
CUSIP No. 28659T200 PAGE 32 OF 46
I. DKAI
(a) Amount beneficially owned: 460 Series C 8% Preferred Stock
convertible into 198,275.86 Common Shares and 59,482 Warrants
exercisable into 59,482 Common Shares
(b) Percent of class: 1.0%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 460 Series C
8% Preferred Stock convertible into 198,275.86 Common
Shares and 59,482 Warrants exercisable into 59,482
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
460 Series C 8% Preferred Stock convertible into
198,275.86 Common Shares and 59,482 Warrants exercisable
into 59,482 Common Shares
J. DKIA
(a) Amount beneficially owned: 827 Series C 8% Preferred Stock
convertible into 356,465.52 Common Shares and 106,939 Warrants
exercisable into 106,939 Common Shares
(b) Percent of class: 1.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 827 Series C
8% Preferred Stock convertible into 356,465.52 Common
Shares and 106,939 Warrants exercisable into 106,939
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
827 Series C 8% Preferred Stock convertible into
356,465.52 Common Shares and 106,939 Warrants
exercisable into 106,939 Common Shares
K. DKG
(a) Amount beneficially owned: 2,060 Series C 8% Preferred Stock
convertible into 887,931.03 Common Shares and 266,379 Warrants
exercisable into 266,379 Common Shares
(b) Percent of class: 4.7%
(c) Number of shares as to which such person has:
Schedule 13G
CUSIP No. 28659T200 PAGE 33 OF 46
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 2,060 Series
C 8% Preferred Stock convertible into 887,931.03 Common
Shares and 266,379 Warrants exercisable into 266,379
Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
2,060 Series C 8% Preferred Stock convertible into
887,931.03 Common Shares and 266,379 Warrants
exercisable into 266,379 Common Shares
L. DKMP
(a) Amount beneficially owned: 3,034 Series C 8% Preferred Stock
convertible into 1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
(b) Percent of class: 6.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 3,034 Series
C 8% Preferred Stock convertible into 1,307,758.62
Common Shares and 392,327 Warrants exercisable into
392,327 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
M. DKS
(a) Amount beneficially owned: 3,034 Series C 8% Preferred Stock
convertible into 1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
(b) Percent of class: 6.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 3,034 Series
C 8% Preferred Stock convertible into 1,307,758.62
Common Shares and 392,327 Warrants exercisable into
392,327 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
Schedule 13G
CUSIP No. 28659T200 PAGE 34 OF 46
(iv) shared power to dispose or to direct the disposition:
3,034 Series C 8% Preferred Stock convertible into
1,307,758.62 Common Shares and 392,327 Warrants
exercisable into 392,327 Common Shares
N. Thomas L. Kempner, Jr.
(a) Amount beneficially owned: 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(11)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
O. Marvin H. Davidson
(a) Amount beneficially owned: 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(12)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
____________________
(11) Subject to the Ownership Limitation (as defined herein).
(12) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 35 OF 46
P. Stephen M. Dowicz
(a) Amount beneficially owned: 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(13)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
Q. Scott E. Davidson
(a) Amount beneficially owned: 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(14)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
___________________________
(13) Subject to the Ownership Limitation (as defined herein).
(14) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 36 OF 46
R. Michael J. Leffell
(a) Amount beneficially owned. 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(15)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
S. Timothy I. Levart
(a) Amount beneficially owned: 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(16)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
T. Robert J. Brivio, Jr.
(a) Amount beneficially owned: 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(17)
______________________
(15) Subject to the Ownership Limitation (as defined herein).
(16) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 37 OF 46
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
U. Eric P. Epstein
(a) Amount beneficially owned: 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(18)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
V. Anthony A. Yoseloff
(a) Amount beneficially owned: 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(19)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
____________________________
(17) Subject to the Ownership Limitation (as defined herein).
(18) Subject to the Ownership Limitation (as defined herein).
(19) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 38 OF 46
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
W. Avram Z. Friedman
(a) Amount beneficially owned: 6,667 Series C 8% Preferred Stock
convertible into 2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
(b) Percent of class: 9.9%(20)
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: 0
(ii) shared power to vote or to direct the vote: 6,667 Series
C 8% Preferred Stock convertible into 2,873,706.89
Common Shares and 862,109 Warrants exercisable into
862,109 Common Shares
(iii) sole power to dispose or to direct the disposition: 0
(iv) shared power to dispose or to direct the disposition:
6,667 Series C 8% Preferred Stock convertible into
2,873,706.89 Common Shares and 862,109 Warrants
exercisable into 862,109 Common Shares
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
The partners, members or stockholders of each of the Reporting Persons,
including the Principals, have the right to participate in the receipt of
dividends from, or proceeds from the sale of, the securities held for the
account of such Reporting Person in accordance with their ownership interests in
such Reporting Person. The Reporting Persons disclaim all beneficial ownership
as affiliates of a registered investment adviser, and, in any case, disclaim
beneficial ownership except as to the extent of their pecuniary interest in the
shares. The Reporting Persons have elected to file Schedule 13G although such
filing may not be required under the Act.
__________________________
(20) Subject to the Ownership Limitation (as defined herein).
Schedule 13G
CUSIP No. 28659T200 PAGE 39 OF 46
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
See Item 4.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
Schedule 13G
CUSIP No. 28659T200 PAGE 40 OF 46
ITEM 10. CERTIFICATION. (if filing pursuant to Rule 13d-1(c))
Each of the Reporting Persons hereby makes the following certification:
By signing below we certify that, to the best of our knowledge and belief,
the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
Schedule 13G
CUSIP No. 28659T200 PAGE 41 OF 46
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
DATED: May 11, 2007 DAVIDSON KEMPNER PARTNERS
By: MHD Management Co.,
its General Partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER INSTITUTIONAL
PARTNERS, L.P.
By: Davidson Kempner Advisers Inc.,
its General Partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: President
M.H. DAVIDSON & CO.
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER INTERNATIONAL, LTD.
By: Davidson Kempner International Advisors,
L.L.C.,
its Investment Manager
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
SERENA LIMITED
By: Davidson Kempner International Advisors,
L.L.C.,
its Investment Manager
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
Schedule 13G
CUSIP No. 28659T200 PAGE 42 OF 46
DAVIDSON KEMPNER HEALTHCARE FUND LP
By: DK Group LLC,
its General Partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DAVIDSON KEMPNER HEALTHCARE
INTERNATIONAL LTD.
By: DK Management Partners LP,
its Investment Manager
By: DK Stillwater GP LLC,
its general partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
MHD MANAGEMENT CO.
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER ADVISERS INC.
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: President
DAVIDSON KEMPNER INTERNATIONAL
ADVISORS, L.L.C.
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DK GROUP LLC
/s/ THOMAS L. KEMPNER, JR.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
Schedule 13G
CUSIP No. 28659T200 PAGE 43 OF 46
DK MANAGEMENT PARTNERS LP
By: DK Stillwater GP LLC,
its general partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DK STILLWATER GP LLC
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Thomas L. Kempner, Jr.
/s/ Marvin H. Davidson
---------------------------------------------
Marvin H. Davidson
/s/ Stephen M. Dowicz
---------------------------------------------
Stephen M. Dowicz
/s/ Scott E. Davidson
---------------------------------------------
Scott E. Davidson
/s/ Michael J. Leffell
---------------------------------------------
Michael J. Leffell
/s/ Timothy I. Levart
---------------------------------------------
Timothy I. Levart
/s/ Robert J. Brivio, Jr.
---------------------------------------------
Robert J. Brivio, Jr.
/s/ Eric P. Epstein
---------------------------------------------
Eric P. Epstein
/s/ Anthony A. Yoseloff
---------------------------------------------
Anthony A. Yoseloff
/s/ Avram Z. Friedman
---------------------------------------------
Avram Z. Friedman
Schedule 13G
CUSIP No. 28659T200 PAGE 44 OF 46
EXHIBIT I
JOINT ACQUISITION STATEMENT
PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge and agree that the foregoing statement on
Schedule 13G is filed on behalf of each of the undersigned and that all
subsequent amendments to this statement on Schedule 13G, shall be filed on
behalf of each of the undersigned without the necessity of filing additional
joint acquisition statements. The undersigned acknowledge that each shall be
responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning him or it contained therein, but
shall not be responsible for the completeness and accuracy of the information
concerning the others, except to the extent that he or it knows or has reason to
believe that such information is inaccurate.
DATED: May 11, 2007 DAVIDSON KEMPNER PARTNERS
By: MHD Management Co.,
its General Partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER INSTITUTIONAL PARTNERS, L.P.
By: Davidson Kempner Advisers Inc.,
its General Partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: President
M.H. DAVIDSON & CO.
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER INTERNATIONAL, LTD.
By: Davidson Kempner International Advisors,
L.L.C.,
its Investment Manager
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
Schedule 13G
CUSIP No. 28659T200 PAGE 45 OF 46
SERENA LIMITED
By: Davidson Kempner International Advisors,
L.L.C.,
its Investment Manager
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DAVIDSON KEMPNER HEALTHCARE FUND LP
By: DK Group LLC,
its General Partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DAVIDSON KEMPNER HEALTHCARE
INTERNATIONAL LTD.
By: DK Management Partners LP,
its Investment Manager
By: DK Stillwater GP LLC,
its general partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
MHD MANAGEMENT CO.
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Managing Partner
DAVIDSON KEMPNER ADVISERS INC.
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: President
DAVIDSON KEMPNER INTERNATIONAL
ADVISORS, L.L.C.
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
Schedule 13G
CUSIP No. 28659T200 PAGE 46 OF 46
DK GROUP LLC
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DK MANAGEMENT PARTNERS LP
By: DK Stillwater GP LLC,
its general partner
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
DK STILLWATER GP LLC
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Name: Thomas L. Kempner, Jr.
Title: Executive Managing Member
/s/ Thomas L. Kempner, Jr.
---------------------------------------------
Thomas L. Kempner, Jr.
/s/ Marvin H. Davidson
---------------------------------------------
Marvin H. Davidson
/s/ Stephen M. Dowicz
---------------------------------------------
Stephen M. Dowicz
/s/ Scott E. Davidson
---------------------------------------------
Scott E. Davidson
/s/ Michael J. Leffell
---------------------------------------------
Michael J. Leffell
/s/ Timothy I. Levart
---------------------------------------------
Timothy I. Levart
/s/ Robert J. Brivio, Jr.
---------------------------------------------
Robert J. Brivio, Jr.
/s/ Eric P. Epstein
---------------------------------------------
Eric P. Epstein
/s/ Anthony A. Yoseloff
---------------------------------------------
Anthony A. Yoseloff
/s/ Avram Z. Friedman
---------------------------------------------
Avram Z. Friedman